LP
XLRN

LMR Partners’s Acceleron Pharma XLRN Stock Holding History

LMR Partners’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-27,190
Closed -$4.68M – 1397
2021
Q3 		$4.68M Buy
+27,190
New +$3.56M 0.05% 271
2020
Q4 		– Sell
-16,593
Closed -$1.87M – 681
2020
Q3 		$1.87M Sell
16,593
-2,928
-15% -$291K 0.04% 160
2020
Q2 		$1.86M Buy
+19,521
New +$1.88M 0.05% 271

LMR Partners's XLRN Position: Q4 2021 in Review

LMR Partners sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 27,190 shares — an estimated $4.68M sold.

LMR Partners first reported a position in XLRN in Q2 2020 and held it in 3 quarters. The position peaked at $4.68M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • LMR Partners reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • LMR Partners sold 27,190 Acceleron Pharma shares in Q4 2021, an estimated $4.68M.
  • LMR Partners first reported a position in Acceleron Pharma in Q2 2020 and held it in 3 quarters.
  • LMR Partners's Acceleron Pharma position peaked at $4.68M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on LMR Partners's 13F filing for Q4 2021, filed 14 Feb 2022.